PlainRecalls
FDA Drug Moderate Class II Terminated

Firmagon (degarelix for injection) 240 mg, Starting Dose, packaged in a kit, Rx only, MFG: Ferring Pharmaceuticals Inc., NDC 55566-8403-01

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1016-2022

Product Description

Firmagon (degarelix for injection) 240 mg, Starting Dose, packaged in a kit, Rx only, MFG: Ferring Pharmaceuticals Inc., NDC 55566-8403-01

Reason for Recall

cGMP deviations: Temperature abuse

Details

Units Affected
15 boxes
Distribution
USA nationwide.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Firmagon (degarelix for injection) 240 mg, Starting Dose, packaged in a kit, Rx only, MFG: Ferring Pharmaceuticals Inc., NDC 55566-8403-01. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 15 boxes.
Why was this product recalled?
cGMP deviations: Temperature abuse
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Moderate. Recall number: D-1016-2022.